Article ID Journal Published Year Pages File Type
6802167 Journal of Substance Abuse Treatment 2016 5 Pages PDF
Abstract
Two in five persons seeking detoxification for an opioid use disorder used a BZD in the prior month. Anxiety was the most common reason patients reported using a benzodiazepine, but they also reported using BZDs to enhance a 'high' and manage opioid withdrawal. Evidence-based discussions about the risks of combining BZDs and opioids, and alternatives to BZDs should be a high priority in detoxification settings.
Related Topics
Life Sciences Neuroscience Biological Psychiatry
Authors
, , , , , ,